Human Immunodeficiency Virus 1 Fusion Inhibitor [EPC]

Known as: HIV Fusion Inhibitor (HIV-1 FI), HIV Entry Inhibitor, Human Immunodeficiency Virus 1 Fusion Inhibitor 
 

Topic mentions per year

Topic mentions per year

2012-2015
0120122015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Several CD4 mimics have been reported as HIV-1 entry inhibitors which can block the interaction between the viral envelope… (More)
Is this relevant?
2016
2016
HIV-1 membrane fusion plays an important role in the process that HIV-1 entries host cells. As a treatment strategy targeting HIV… (More)
Is this relevant?
2015
2015
Enfuvirtide (T20), is the first HIV fusion inhibitor approved for treatment of HIV/AIDS patients who fail to respond to the… (More)
Is this relevant?
2013
2013
To date, several small molecules of CD4 mimics, which can suppress competitively the interaction between an HIV-1 envelope… (More)
Is this relevant?
2013
2013
Fusion inhibitors are a class of antiretroviral drugs used to prevent entry of HIV into host cells. Many of the fusion inhibitors… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
T-20 and T-1249 fusion inhibitor peptides were shown to interact with 1-palmitoyl-2-oleyl-phosphatidylcholine (POPC) (liquid… (More)
  • figure 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
T-1249 is a peptide that inhibits the fusion of HIV envelope with the target cell membrane. Recent results indicate that T-1249… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?